Germany · Biopharma startup
Germany · Lipocalyx
Lipocalyx GmbH develops transfection reagents for siRNA.
Funding reportedLast round: Seed
Follow Lipocalyx and see its new rounds in your feed.Start following
What company datasets say Lipocalyx raised
Funding, as reported
Reported in all500kin the source's currency
Rounds2
Last roundSeed
Last round dateFeb 2013
Investors listed2
Biopharma in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Lipocalyx in front of investors. Or tell us what we have wrong.